Moona Khan

Moona Khan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
ANAlmas Naeem
Almas Naeem
NJNoor Jahan
Noor Jahan
MKMoona Khan
Moona Khan
GAGhulam Abbas
Ghulam Abbas
FSFaheema Siddiqui
Faheema Siddiqui
WFWaqas Ahmed Farooqui
Waqas Ahmed Farooqui
Leflunomide is an isoxazole immunomodulating drug used to treat rheumatoid arthritis (RA). It is adopted as a metal-containing molecule to proceed with saturated salts of essential and detected metals; it amends the pharmacokinetic and pharmacodynamics activity of leflunomide to provide [M(Lef)4]X2-type complexes. Earlier it has been reported that after forming complexes with metals, leflunomide anti-arthritic activity was significantly altered in an acute arthritic model. In the present study, we evaluated the possible modification in anti-arthritic activities of leflunomide–metal complexes (Mg+2, Ca+2, Fe+2, Zn+2) with and without an anti-depressant drug, i.e., fluoxetine (10 mg/kg) in a chronic AIA model. Rats (n = 5) were administered with 0.1 mL of CFA into the right hind paw while treated groups received leflunomide and its metal complexes orally (3.2 mg/kg) for 24 days. On the final day of experiment, rats were sacrificed; a specific rat immunoassay ELISA kit was used to assess TNF-α in serum samples and read at 450 nm; a tissue sample of a paw was homogenized in a phosphate buffer using DCFH-DA dye for binding to assess ROS. A rat’s brain sample was homogenized and evaluated for tryptophan, serotonin (5-HT), and HIAA by RP-HPLC with EC detector. The overall TNF production was altered in treated rats. In addition, a decreased ROS was observed in all categories, except lef+Mg+2 group. Moreover, depletion in the brain indolamine levels were found in treated groups; an upraised level of these indolamines was observed when fluoxetine was added. It is concluded that metals affect leflunomide activity on complexation and simultaneous administration of fluoxetine cope up with the depression in arthritic-induced rats.

14 December 2024 in RADS Journal of Pharmacy and Allied Health Sciences
Verified
Journal Article
Open access
PDF file
MKMoona Khan
Moona Khan
SSSobia Shabbir
Sobia Shabbir
DSDarakhshan Saleem
Darakhshan Saleem
SMShafaque Mk
Shafaque Mk
NSNadia Sikandar
Nadia Sikandar
JSJawaid Shabir
Jawaid Shabir
Background: Drug-drug interactions have the potential to significantly impact the pharmacological profiles of individual medications, leading to altered therapeutic outcomes and potential adverse effects. In this study, we explored the interactions between three commonly used drugs, namely leflunomide, indomethacin, and furosemide, utilizing a UV-Visible spectrophotometer technique to assess their spectral characteristics. The UV-Visible spectrophotometer was employed to analyze the absorbance spectra of each drug individually and in combination at various concentrations. Methodology: This research aims to explore the interactions between indomethacin and furosemide with leflunomide using in vitro UV-Visible spectrophotometry technique. Results: Our results revealed that the combination of leflunomide with indomethacin and furosemide led to altered spectral patterns compared to the individual drugs. Specific shifts in peak wavelengths and changes in absorption intensities were observed, indicating potential drug interactions. Furthermore, the quantitative analysis allowed us to determine the degree of interaction between the drugs, elucidating the magnitude of the impact on their respective UV-Visible spectra. Conclusion: The findings from this study can provide valuable insights into potential drug-drug interactions when leflunomide is co-administered with indomethacin and furosemide. The knowledge gained from this research will aid healthcare professionals in making informed decisions when prescribing these medications concurrently, ultimately contributing to safer and more effective patient care.

31 July 2023 in RADS Journal of Pharmacy and Allied Health Sciences
Verified
Journal Article
Open access
PDF file
MKMoona Khan
Moona Khan
SMShafaque Mk
Shafaque Mk
KRKiran Rafiq
Kiran Rafiq
DSDarakhshan M. Saleem
Darakhshan M. Saleem
KMKashif Mk
Kashif Mk
MAMahwish Akhtar
Mahwish Akhtar
Background: Rheumatoid arthritis (RA) is a neuro-immune disorder which causes neurological problem majorly depression along with joints soreness. Reduced brain indolamines level is one the reason among them Objectives: The core objective of this research is to treat the RA associated depressive arthritic rats with fluoxetine (very effective SSRIs). For this purpose, chronic arthritis was induced in healthy female rats by adjuvant. Brain indolamines (BI) levels (Tryptophan, serotonin and HIAA) were estimated in three groups, one is of healthy rats having no arthritis i.e. No AIA (positive control), second adjuvant-induced arthritic (AIA) rats that act as negative control and third is test group i.e. (Fluox AIA) AIA rats receiving fluoxetine (10mg/Kg, orally). As decrease concentration of BI contribute to make body depressed and elevated levels of theses markers by fluoxetine helps to improve the depressant condition in AIA rats. Methodology: Adjuvant induced arthritic rat (AIA) model were used in this study which having same pathological conditions as RA patients possess. To induce arthritis1 mg of fresh lyophilized Mycobacterium tuberculosis H37Ra (MT H37Ra; DIFCO Laboratories, Detroit, MI, USA) in 0.1 ml of liquid paraffin oil was injected into the hind paw of all female Sprague-Dawley rats. Rats were grouped into three categories i.e. positive control (having no arthritis), AIA negative control and AIA Fluox (receiving fluoxetine). Change in paw volumes was assessed to observe the arthritic progression. Levels of BI were estimated through HPLC-EC technique to determine anti-depressant effect of fluoxetine. Data was analyzed by one way ANOVA using Tukey’s post hoc analysis. Results: Major increase (p<0.005) were found in all BI in arthritic rats receiving fluoxetine when compared against AIA control group. Conclusion: Brain indolamines level increased significantly in AIA rats receiving fluoxetine when compared with control which help them to improve depressant condition associated with RA.